Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963500693> ?p ?o ?g. }
- W1963500693 endingPage "104" @default.
- W1963500693 startingPage "95" @default.
- W1963500693 abstract "International Journal of DermatologyVolume 17, Issue 2 p. 95-104 CHEMOTAXIS IN CUTANEOUS DISEASE MARK V. DAHL M.D., MARK V. DAHL M.D. From the Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota.Search for more papers by this author MARK V. DAHL M.D., MARK V. DAHL M.D. From the Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota.Search for more papers by this author First published: March 1978 https://doi.org/10.1111/j.1365-4362.1978.tb06118.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Rebuck, J. W., and Crowley, J. H.: A method of studying leukocytic function in vivo. Ann NY Acad. Sci. 58: 757, 1955. 2 Mass, M. F., Dean, P. B., Weston, W. L., and Hombert, J. R.: Leukocyte migration in vivo: A new method of study. J. Lab. Clin. Med. 86: 1040, 1975. 3 Boyden, S. V.: The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J. Exp. Med. 115: 453, 1962. 4 Mowat, A. G., and Baum, J.: Chemotaxis of polymorphonuclear leukocytes from patients with rhematoid arthritis. J. Clin. Invest. 50: 2541, 1971. 5 Hill, H. R., Hogan, N. A., Mitchell, T. G., and Quie, P. G.: Evaluation of a cytocentrifuge method for measuring neutrophil chemotaxis. J. Lab. Clin. Med. 86: 703, 1975. 6 Nelson, R. D., Quie, P. G., and Simmons, R. L.: Chemotaxis under agarose: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J. Immunol. 115: 1650, 1975. 7 Wilkinson, P. C.: Chemotaxis and inflammation. London , Churchill Livingstone, 1974. 8 Ward, P. A.: Leukotaxis and leukotactic disorders: A review. Am. J. Pathol. 77: 520, 1974. 9 Keller, H. V., and Sorkin, E.: Studies on chemotaxis. V. On the chemotactic effect of bacteria. Int. Arch Allergy 31: 505, 1967. 10 Lachmann, P. J., Kay, A. B., and Thompson, R. A.: The chemotactic activity for neutrophil and esoinophil leukocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the “reactive lysis” procedure. Immunology 19: 895, 1970. 11 Ruddy, S., Gigli, I., and Austen, K. F.: The complement system of man. N. Engl. J. Med. 287: 489, 545, 592, 642, 1972. 12 Hill, J. H., and Ward, P. A.: The philogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133: 885, 1971. 13 Ward, P. A., Capitis, J., Conroy, M. C., and Lepow, I. H.: Generation by bacterial proternases of leukotactic factors from human serum and C3 and C5. J. Immunol. 110: 1003, 1973. 14 Ward, P. A., Cohen, S., and Flanagan, T. D.: Leukotactic factors elaborated by virus infected tissues. J. Exp. Med. 135: 1095, 1972. 15 Ramsey, W. S.: Locomotion of human polymorphonuclear leukocytes. Exp. Cell Res. 72: 489, 1972. 16 Gallin, J. I., and Rosenthal, A. S.: The regulatory role of divalent cations in human granulocyte chemotaxis: Evidence for an association between calcium exchanges and microtubule assembly. J. Cell Biol. 62: 594, 1974. 17 Rydgren, L., Simmingskold, G., Bandmann, U., and Norberg, B.: The role of cytoplasmic microtubules in polymorphonuclear chemotaxis. Exp. Cell Res. 99: 207, 1976. 18 Ward, P. A., and Becker, E. L.: The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J. Exp. Med. 127: 693, 1968. 19 Carruthers, B. M.: Leukocyte mobility. II. Effect of absence of glucose in medium: Effect of presence of deoxyglucose, dinitrophenyl, puromycin, actinomycin D, and trypsin on the response to I chemotactic substance, Can. J. Physiol. Pharmacol. 45: 269, 1967. 20 Goetzl, E. J., and Austen, K. F.: Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. J. Clin. Invest. 53: 591, 1974. 21 Hill, H. R., Estensen, R. D., Quie, P. G., Hogan, N. A., and Coldberg, N. D.: Modulation of human neutrophil chemotactic responses by cyclic 3′5′ adenosine monophosphate. Metabolism 24: 227, 1975. 22 Borel, J. F.: Studies on chemotaxis: Effect of subcellular leukocyte fractions on neutrophils and macrophages. Int. Arch Allergy 39: 247, 1970. 23 Tse, R. L., and Phelps, P.: Polymorphonuclear leukocyte mobility in vitro. V. Release of chemotactic activity following phagocytosis of calcium pyrophosphate crystals, diamond dust and urate crystals. J. Lab. Clin. Med. 76: 403, 1970. 24 Ward, P. A.: The regulation of teukotactic mediators. Antibiot. Chemother. 19: 333, 1974. 25 Miles, A. A., Miles, E. M., and Burke, J.: Value and duration of defense reactions of the skin to primary lodgement of bacteria. Br. J. Exp. Pathol. 39: 79, 1957. 26 Buckley, R. H., and Fiscus, S. A.: Serum IgD and IgE concentrations in immunodeficiency diseases. J. Clin. Invest. 55: 157, 1972. 27 Dahl, M. V., Greene, W. H., and Quie, P. G.: Infection, dermatitis, elevated IgE, and impaired neutrophil chemotaxis: A possible relationship. Arch. Dermatol. In press. 112: 1387, 1976. 28 Hill, H. R., and Quie, P. G.: Raised serum IgE levels in defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infection. Lancet 1: 183, 1974. 29 Hill, H. R., Ochs, H. D., Quie, P. G., Clark, R. A., Pabst, H. F., Klebanoff, S. J., and Wedgwood, R. J.: Defect in neutrophil granulocyte chemotaxis in Jobs syndrome of recurrent “cold” staphylococcal abscesses. Lancet II: 617, 1974. 30 Hill, H. R., and Quie, P. G.: Defective neutrophil chemotaxis associated with hyperimmuno-globulinemia E. In the Phagocytic Cell in Host Resistance. Edited by J. Ballanti, and D. Bayton, New York , Raven Press, 1975. 31 Pincus, S. H., Thomas, I. T., Clark, R. A., and Ochs, H. D.: Defective neutrophil chemotaxis with variant ichthyosis, hyperimmunoglobulinemia E, and recurrent infections. J. Pediatr. 87: 908, 1975. 32 Dahl, M. V., Matula, G., Leonards, R., and Tuffanelli, D. L.: Incontinentia pigmenti and defective neutrophil chernotaxis. Arch Dermatol. 111: 1603, 1975. 33 Paslin, D., and Norman, M. E.: Atopic dermatitis and impaired neutrophil chernotaxis in Jobs syndrome. Arch. Dermatol. 113: 801, 1977. 34 Clark, R. A., Root, R. K., Kimball, H. R., and Kirkpatrick, C. H.: Defective neutrophil chemotaxis in a child with recurrent infection. Ann. Int. Med. 78: 595, 1973. 35 Fortan, G., Lorente, F., Garcia-Rodriguez, M. C., and Ojeda, J. A.: Defective neutrophil chemotaxis and hyperirnmunoglobulinemia E: A reversible defect? Acta Ped. Scand. 65: 509, 1976. 36 Rogge, J. L., and Hanifin, J. M.: Depressed chemotaxis and leukocyte transformation in severe atopic dermatitis. Arch. Dermatol. In press. 37 Van Scoy, R. E., Hill, H. R., Ritts, R. E., and Quie, P. G.: Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E. Ann. Int. Med. 82: 766, 1975. 38 Altman, L. C., Snyderman, R., and Blaese, R. M.: Abnormalities of chemotactic lymphokine synthesis and rnononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome. J. Clin. Invest. 54: 486, 1974. 39 Weston, W. L.: Disorders of phagocytic dysfunction. Arch. Dermatol. 112: 1589, 1976. 40 Clark, R. A., and Kimball, H. R.: Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J. Clin. Invest. 50: 2645, 1971. 41 Miller, M. E., Oski, F. A., and Harris, M. B.: The lazy leukocyte syndrome. A new disorder of neutrophil dysfunction. Lancet 1: 565, 1971. 42 Weston, W. L., Huff, J.C., Humbert, J. R., Hambridge, K. M., Nelder, K. H., and Walravens, P. A.: Zinc correction of defective chemotaxis in aerodermatitis enteropathica. Arch. Dermatol. 113: 422, 1977. 43 Snyderman, R., Altman, L. C., Frankel, A., and Blaese, R. M.: Defective mononuclear leukocyte chemotaxis: A previously unrecognized immune dysfunction. Ann. Int. Med. 78: 509, 1973. 44 Miller, M. E., Norman, M. E., Koblenzer, P. I., and Schonauer, T.: A new familial defect of neutrophil movement. J. Lab. Clin. Med. 82: 1, 1973. 45 Synderman, R., and Stahl, C.: Defective immune effector function in patients with neoplastic and immune deficiency diseases. In The Phagocytic Cell and Host Resistance. Edited by J. Balanti, and D. Bayton, New York , Raven Press, 1975. 46 Zbar, B., Wepsic, H. T., Rapp, H. J., Stewart, L. C., and Borsos, T.: Two step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction of a cell fraction containing lymphocytes and neutrophils. J. Nat. Cancer Inst. 44: 710, 1970. 47 Seitz, L. E., Golitz, L. E., Weston, W. L., Aeling, J. E., and Dustin, R. D.: Defective monocyte chemotaxis in mycosis fungoides. Arch Dermatol. 113: 1055, 1977. 48 Boxer, L. A., Hedley-Whyte, E. T., and Stossell, T. P.: Neutrophil actin dysfunction and abnormal neutrophil behavior. N. Engl. J. Med. 291: 1093, 1974. 49 Kleinerman, E. S., Snyderman, R., and Daniels, C. A.: Depression of human monocyte chemotaxis by herpes simplex and influenza viruses. J. Immunol. 113: 1562, 1974. 50 Jacobs, J. C., and Goetzl, E. J.: Streaking leukocyte factor, arthritis, and pyoderma gangrenosum. Pediatr. 56: 570, 1975. 51 Matsumera, N., and Mizushima, Y.: Leukocyte movement and Colchicine treatment in Behçet's dis-disease. Lancet 11: 813, 1975. 52 Malawista, S. E., and Bensch, K. G.: Human polymorphonuclear leukocytes: Demonstration of microtubials and effect of colchicine. Science 156: 521, 1967. 53 Tagami, H., and Ofuju, S.: Leukotactic propertiesof soluble substances in psoriasis scale. Br. J. Dermatol. 95: 1, 1976. 54 Ketchel, M. M., Favour, C. B., and Sturgis, S. H.: The in vitro action of hydrocortisone on leukocyte migration. J. Exp. Med. 107: 211, 1958. 55 Ward, P. A.: The chemosuppression of chemotaxis. J. Exp. Med. 124: 209, 1966. 56 Callin, J. I., Durocher, J. R., and Kaplan, A. P.: Interaction of leukocyte chemotactic factors with the cell surface: I. Chemotactic factor-induced changes in human granulocyte surface change. J. Clin. Invest. 55: 967, 1975. 57 Martin, R. R., Warr, G. A., Couch, R. B., Yeager, H., and Knight, V.: Effects of tetracycline on leukotaxis. J. Infect. Dis. 129: 110, 1974. 58 Bandmann, U., Norberg, B., and Simmingskold, M. B.: Griseofulvin inhibition of polymorphonuclear leukocyte chemotaxis in Boyden chambers. Scand. J. Haematol. 15: 81, 1975. 59 Bandmann, U., Rydgren, L., and Norberg, B.: The difference between random movement and chemotaxis: Effects of antitubulins on neutrophil granulocyte locomotion. Exp. Cell Res. 88: 63, 1974. 60 Bourne, H. R., Melmon, K. L., and Lichentenstein, L. M.: Histamine augments leukocyte adenosine 3′5′ monophosphate and blocks antigenic histamine release. Science 173: 743, 1971. 61 Goetzl, E. J., Wasserman, S. I., Gigli, I., and Austen, K. F.: Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J. Clin. Invest. 53: 813, 1974. 62 Fischer, G. W., Podgore, J. K., and Bass, J. W.: Immunopotentiation by Levamisole. Lancet I: 1137, 1975. 63 Ray, T. L., and Wuepper, K. D.: Activation of the alternate (properdin) pathway of complement by Candida albicans and related species. J. Invest. Dermatol. 67: 700, 1976. 64 Sohnle, P. G., Frank, M. M., and Kirkpatrick, C. H.: Deposition of complement components in the cutaneous lesions of chronic mucocutaneous candidiasis. Clin. Immunol. Immunopathol. 5: 340, 1976. 65 Jones, H. E., Reinhardt, J. H., and Rinaldi, M. G.: Model dermatophytosis in naturally infected subjects. Arch. Dermatol. 110: 369, 1974. 66 Ward, P. A., Remold, H. G., and David, J. R.: Leukotactic factor produced by sensitized lymphocytes. Science 163: 1079, 1969. 67 Diaz-Perez, J. L., and Jordon, R. E.: The complement system ip bullous pemphigoid IV. Chemotactic activity in blister fluid. Clin., Immunol. Immunopathol. 5: 360, 1976. 68 Rowers, T. K., Cradduck, P. R., and Jacob, H. S.: Complement (C') induced granulocyte paralysis due to drug allergy. Clin. Res. 23: 489A, 1975. 69 Miller, M. E.: Pathology of chemotaxis and random mobility. Seminar in Hematology 12: 59, 1975. Citing Literature Volume17, Issue2March 1978Pages 95-104 ReferencesRelatedInformation" @default.
- W1963500693 created "2016-06-24" @default.
- W1963500693 creator A5032363032 @default.
- W1963500693 date "1978-03-01" @default.
- W1963500693 modified "2023-09-26" @default.
- W1963500693 title "CHEMOTAXIS IN CUTANEOUS DISEASE" @default.
- W1963500693 cites W1486868695 @default.
- W1963500693 cites W1489857057 @default.
- W1963500693 cites W1547566916 @default.
- W1963500693 cites W1556117847 @default.
- W1963500693 cites W1593131145 @default.
- W1963500693 cites W1607101145 @default.
- W1963500693 cites W1607461883 @default.
- W1963500693 cites W1819732475 @default.
- W1963500693 cites W1975156288 @default.
- W1963500693 cites W1975989837 @default.
- W1963500693 cites W1979002030 @default.
- W1963500693 cites W1981828352 @default.
- W1963500693 cites W1992326371 @default.
- W1963500693 cites W1993749222 @default.
- W1963500693 cites W1995601440 @default.
- W1963500693 cites W1996511737 @default.
- W1963500693 cites W2000362479 @default.
- W1963500693 cites W2000657371 @default.
- W1963500693 cites W2002307260 @default.
- W1963500693 cites W2011906524 @default.
- W1963500693 cites W2013858124 @default.
- W1963500693 cites W2014482706 @default.
- W1963500693 cites W2015199882 @default.
- W1963500693 cites W2016587389 @default.
- W1963500693 cites W2021401584 @default.
- W1963500693 cites W2026098142 @default.
- W1963500693 cites W2027472039 @default.
- W1963500693 cites W2028084628 @default.
- W1963500693 cites W2028349801 @default.
- W1963500693 cites W2034785432 @default.
- W1963500693 cites W2038140160 @default.
- W1963500693 cites W2044615120 @default.
- W1963500693 cites W2050070158 @default.
- W1963500693 cites W2057700297 @default.
- W1963500693 cites W2057852724 @default.
- W1963500693 cites W2075166342 @default.
- W1963500693 cites W2079993486 @default.
- W1963500693 cites W2083587049 @default.
- W1963500693 cites W2083705089 @default.
- W1963500693 cites W2087708213 @default.
- W1963500693 cites W2111288834 @default.
- W1963500693 cites W2117228071 @default.
- W1963500693 cites W2166253563 @default.
- W1963500693 cites W2255132411 @default.
- W1963500693 cites W2336456478 @default.
- W1963500693 cites W4230106096 @default.
- W1963500693 cites W4232342645 @default.
- W1963500693 cites W4238133687 @default.
- W1963500693 cites W4238214492 @default.
- W1963500693 cites W4239251795 @default.
- W1963500693 cites W4243556916 @default.
- W1963500693 cites W4253202052 @default.
- W1963500693 cites W4253613379 @default.
- W1963500693 doi "https://doi.org/10.1111/j.1365-4362.1978.tb06118.x" @default.
- W1963500693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/348618" @default.
- W1963500693 hasPublicationYear "1978" @default.
- W1963500693 type Work @default.
- W1963500693 sameAs 1963500693 @default.
- W1963500693 citedByCount "12" @default.
- W1963500693 crossrefType "journal-article" @default.
- W1963500693 hasAuthorship W1963500693A5032363032 @default.
- W1963500693 hasConcept C126322002 @default.
- W1963500693 hasConcept C16005928 @default.
- W1963500693 hasConcept C170493617 @default.
- W1963500693 hasConcept C203014093 @default.
- W1963500693 hasConcept C54166955 @default.
- W1963500693 hasConcept C71924100 @default.
- W1963500693 hasConceptScore W1963500693C126322002 @default.
- W1963500693 hasConceptScore W1963500693C16005928 @default.
- W1963500693 hasConceptScore W1963500693C170493617 @default.
- W1963500693 hasConceptScore W1963500693C203014093 @default.
- W1963500693 hasConceptScore W1963500693C54166955 @default.
- W1963500693 hasConceptScore W1963500693C71924100 @default.
- W1963500693 hasIssue "2" @default.
- W1963500693 hasLocation W19635006931 @default.
- W1963500693 hasLocation W19635006932 @default.
- W1963500693 hasOpenAccess W1963500693 @default.
- W1963500693 hasPrimaryLocation W19635006931 @default.
- W1963500693 hasRelatedWork W1871346714 @default.
- W1963500693 hasRelatedWork W1976013595 @default.
- W1963500693 hasRelatedWork W1997813925 @default.
- W1963500693 hasRelatedWork W2000349373 @default.
- W1963500693 hasRelatedWork W2002193970 @default.
- W1963500693 hasRelatedWork W2013858124 @default.
- W1963500693 hasRelatedWork W2028440027 @default.
- W1963500693 hasRelatedWork W2033649814 @default.
- W1963500693 hasRelatedWork W2462695130 @default.
- W1963500693 hasRelatedWork W4297184974 @default.
- W1963500693 hasVolume "17" @default.
- W1963500693 isParatext "false" @default.
- W1963500693 isRetracted "false" @default.
- W1963500693 magId "1963500693" @default.